National Bank of Canada
ROIV icon

National Bank of Canada’s Roivant Sciences ROIV Stock Holding History

National Bank of Canada’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.2M Sell
2,773,874
-3,524,126
-56% -$104M 0.07% 212
2026
Q1 		$174M Buy
6,298,000
+4,258,000
+209% +$109M 0.16% 114
2025
Q4 		$44.3M Buy
+2,040,000
New +$40.2M 0.04% 338

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

National Bank of Canada's ROIV Position: Q2 2026 in Review

National Bank of Canada reduced its Roivant Sciences (ROIV) stake by 56% in Q2 2026, selling an estimated $104M and leaving 2,773,874 shares worth $98.2M. The position accounts for 0.07% of the portfolio, ranked #212.

National Bank of Canada first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. The position peaked at $174M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • National Bank of Canada held 2,773,874 shares of Roivant Sciences worth $98.2M as of Q2 2026.
  • National Bank of Canada sold 3,524,126 Roivant Sciences shares in Q2 2026, an estimated $104M.
  • Roivant Sciences made up 0.07% of National Bank of Canada's portfolio in Q2 2026, its #212 holding.
  • National Bank of Canada first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • National Bank of Canada's Roivant Sciences position peaked at $174M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.